A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19-50
SponsorAddpharma Inc.
About this trial
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Eligibility criteria
Qualifiers
Body weight equal to or greater than 50.0kg and equal to or less than 90.0kg and Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
The Age equal to or greater than 19 and equal to or less than 50 in healthy volunteers at the time of screening visit
Negative result from Serum Helicobacter pylori antibody at the time of screening visit
Disqualifiers
Patients with trouble performing pH monitor catheter
Trial design
Treatments tested in this trial
- AD-120A
- AD-120
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov